Skip to main content

Table 3 Impacts of diverse delayed extents on the subjective evaluation of sexual potency at the 6th month end after treatments

From: Risk factors and negative consequences of patient’s delay for penile carcinoma

IIEF-15 domains

Erectile function (19–30a vs. 0–18)

Orgasmic function (7–10a vs. 0–6)

Sexual desire (7–10a vs. 0–6)

Intercourse satisfaction (10–15a vs. 0–9)

Overall satisfaction (7–10a vs. 0–6)

OR (95 % CI)

p value

OR (95 % CI)

p value

OR (95 % CI)

p value

OR (95 % CI)

p value

OR (95 % CI)

p value

Undelayed (n = 58)

Reference

 

Reference

 

Reference

 

Reference

 

Reference

 

Delay 1–3 months (n = 60)

1.554 (0.650–3.712)

0.319

1.660 (0.755–3.650)

0.206

1.529 (0.508–4.608)

0.448

1.571 (0.702–3.519)

0.270

1.643 (0.708–3.812)

0.246

Delay 3–6 months (n = 37)

2.913 (1.151–7.371)

0.021

2.716 (1.135–6.498)

0.023

2.391 (0.756–7.565)

0.131

2.977 (1.233–7.190)

0.014

2.921 (1.177–7.250)

0.019

Delay >6 months (n = 41)

3.344 (1.358–8.231)

0.007

3.010 (1.288–7.034)

0.010

3.178 (1.067–9.466)

0.032

3.639 (1.541–8.594)

0.003

3.311 (1.368–8.009)

0.007

  1. IIEF International Index of Erectile Function, OR odds ratios, CI confidence interval
  2. aNo or mild dysfunction for each domain of IIEF-15 [8]